-
lung tumors. We utilize a multifaceted approach that encompasses preclinical studies in immunocompetent syngeneic and genetically engineered co-mutational models of KRAS-mutant NSCLC as well as PDX/CDXs
Enter an email to receive alerts for model-driven-engineering "https:" positions